Skip to main content
. 2020 Jul 2;25(26):1900317. doi: 10.2807/1560-7917.ES.2020.25.26.1900317

Table 2. Univariable and multivariable analyses of established predictors of extended-spectrum β-lactamase-producing Enterobacterales infection, University Hospital Basel, Switzerland, January 2010–December 2016 (n = 376).

Parameter Cases (ESBL-positive)
(n = 94)
Controls (ESBL-negative)
(n = 282)
Univariable analyses Multivariable analysesa
n % n % OR 95% CI p value OR 95% CI p value
Parameters by Tumbarello et al. [ 11 ]
Recent hospitalisationb 60 64 135 48 2.16 1.27–3.69 0.005 NS NA NA
Admission from other healthcare facility 17 18 26 9 2.18 1.12–4.25 0.023 3.07 1.37–6.88 0.007
Antibiotic therapy with β-lactams or fluoroquinolonesc 60 64 74 26 4.96 3.02–8.16 < 0.001 4.10 2.17–7.74 < 0.001
Urinary catheterisationd 28 30 47 17 2.17 1.25–3.77 0.006 NS NA NA
Charlson Comorbidity Index ≥ 4 16 17 44 16 1.10 0.59–2.05 0.767 NS NA NA
Age ≥ 70 years 47 50 165 59 1.21 0.75–1.95 0.444 NS NA NA
Parameters by Goodman et al. [ 12 ]
History of ESBL-PE colonisation/infectione 32 34 8 3 18.06 7.02–46.47 < 0.001 15.32 5.52–42.53 < 0.001f
Hospitalisation in ESBL high-burden regione,g 1 1 2 1 1.50 0.14–16.54 0.741 NS NA NA
Chronic indwelling vascular hardwareh 21 22 45 16 1.61 0.86–3.00 0.136 NS NA NA
Any antibiotic exposure within last 6 monthsi 56 60 74 26 5.85 3.21–10.64 < 0.001 NS NA NA
Age ≥ 43 years 87 93 260 92 1.25 0.49–3.20 0.647 NS NA NA

CI: confidence interval; ESBL: extended-spectrum β-lactamase; ESBL-PE: extended-spectrum β-lactamase-producing Enterobacterales; OR: odds ratio NA: not applicable; NS: not selected.

a Multivariable analyses included all variables presented in the table, only variables chosen by stepwise logistic regression using stepwise forward and backward selection, as well as Akaike information criterion (AIC), are presented in the table.

b More than 2 days within 12 months before index hospitalisation.

c Lasting > 48 h during the 3 months preceding admission.

d Within 30 days before index blood culture.

e Within 6 months before index hospitalisation.

f Selected by lasso regression and recursive partitioning algorithms (decision tree statistics).

g India (1), France (1) and North Macedonia (1).

h Central venous catheters (including peripherally inserted central catheter (PICC)-lines, ports, pace makers) and central dialysis catheters.

i Extended-spectrum penicillins, third/fourth generation cephalosporins, carbapenems, aztreonam, fluoroquinolones and aminoglycosides.

Bold print indicates significant p values.